Goldman Sachs’s PHARMACYCLICS INC PCYC Stock Holding History

Goldman Sachs’s Portfolio PCYC Stock Details PCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-93,600	Closed	-$24M	–	7660
2015 Q1	$24M	Buy	93,600 +16,600	+22%	+$3.2M	0.01%	1626
2014 Q4	$9.41M	Buy	77,000 +47,000	+157%	+$6.01M	﹤0.01%	2388
2014 Q3	$3.52M	Hold	30,000	–	–	﹤0.01%	3363
2014 Q2	$2.69M	Buy	30,000 +700	+2%	+$65.7K	﹤0.01%	3683
2014 Q1	$2.94M	Sell	29,300 -9,600	-25%	-$1.25M	﹤0.01%	3597
2013 Q4	$4.12M	Buy	+38,900	New	+$4.72M	﹤0.01%	3303
2013 Q3	–	Sell	-268,700	Closed	-$21.4M	–	6838
2013 Q2	$21.4M	Buy	+268,700	New	+$22M	0.01%	1502

Other funds holding PCYC

Credit Agricole Montrouge Cedex, France $38.1B AUM

Goldman Sachs's PCYC Position: Q2 2015 in Review

Goldman Sachs sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 362,834 shares — an estimated $92.9M sold.

Goldman Sachs first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $131M in Q1 2014. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

Goldman Sachs reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
Goldman Sachs sold 362,834 PHARMACYCLICS INC shares in Q2 2015, an estimated $92.9M.
Goldman Sachs first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
Goldman Sachs's PHARMACYCLICS INC position peaked at $131M in Q1 2014.
1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.